 | total:705
[2013]
| 241. | Adipose deficiency of Nrf2 in ob/ob mice results in severe metabolic syndrome..[Diabetes,62(3),(2013),845-854]Xue, Peng Hou, Yongyong Chen, Yanyan Yang, Bei Fu, Jingqi Zheng, Hongzhi Yarborough, Kathy Woods, Courtney G Liu, Dianxin Yamamoto, Masayuki Zhang, Qiang Andersen, Melvin E Pi, Jingbo
10.2337/db12-0584
  |
| |
| 242. | Keap1 knockdown increases markers of metabolic syndrome after long-term high fat diet feeding..[Free Radic Biol Med,61C,(2013),85-94]More, Vijay R Xu, Jialin Shimpi, Prajakta C Belgrave, Clyde Luyendyk, James P Yamamoto, Masayuki Slitt, Angela L
10.1016/j.freeradbiomed.2013.03.007
|
| |
| 243. | Roles of Keap1-Nrf2 system in upper aerodigestive tract carcinogenesis..[Cancer Prev Res (Phila),6(2),(2013),149-159]Ohkoshi, Akira Suzuki, Takafumi Ono, Masao Kobayashi, Toshimitsu Yamamoto, Masayuki
10.1158/1940-6207.CAPR-12-0401-T
|
| |
| 244. | Exacerbated airway toxicity of environmental oxidant ozone in mice deficient in Nrf2..[Oxid Med Cell Longev,2013,(2013),254069]Cho, Hye-Youn Gladwell, Wesley Yamamoto, Masayuki Kleeberger, Steven R
10.1155/2013/254069
|
| |
| 245. | Roles nrf2 plays in myeloid cells and related disorders..[Oxid Med Cell Longev,2013,(2013),529219]Kobayashi, Eri Suzuki, Takafumi Yamamoto, Masayuki
10.1155/2013/529219
|
| |
| 246. | 4-Hydroxy hexenal derived from docosahexaenoic acid protects endothelial cells via Nrf2 activation..[PLoS One,8(7),(2013),e69415]Ishikado, Atsushi Morino, Katsutaro Nishio, Yoshihiko Nakagawa, Fumiyuki Mukose, Atsushi Sono, Yoko Yoshioka, Nagisa Kondo, Keiko Sekine, Osamu Yoshizaki, Takeshi Ugi, Satoshi Uzu, Takashi Kawai, Hiromichi Makino, Taketoshi Okamura, Tomio Yamamoto, Masayuki Kashiwagi, Atsunori Maegawa, Hiroshi
10.1371/journal.pone.0069415
|
| |
[2012]
| 247. | Metabolic stress response implicated in diabetic retinopathy: the role of calpain, and the therapeutic impact of calpain inhibitor..[Neurobiol Dis,48(3),(2012),556-567]Shanab, Ahmed Y Nakazawa, Toru Ryu, Morin Tanaka, Yuji Himori, Noriko Taguchi, Keiko Yasuda, Masayuki Watanabe, Ryo Takano, Jiro Saido, Takaomi Minegishi, Naoko Miyata, Toshio Abe, Toshiaki Yamamoto, Masayuki
10.1016/j.nbd.2012.07.025
|
| |
| 248. | Contribution of GATA1 dysfunction to multi-step leukemogenesis..[Cancer Sci,103(12),(2012),2039-2044]Shimizu, Ritsuko Yamamoto, Masayuki
10.1111/cas.12007
|
| |
| 249. | Nrf2 in bone marrow-derived cells positively contributes to the advanced stage of atherosclerotic plaque formation..[Free Radic Biol Med,53(12),(2012),2256-2262]Harada, Nobuhiko Ito, Koichi Hosoya, Tomonori Mimura, Junsei Maruyama, Atsushi Noguchi, Noriko Yagami, Ken-ichi Morito, Naoki Takahashi, Satoru Maher, Jon M Yamamoto, Masayuki Itoh, Ken
10.1016/j.freeradbiomed.2012.10.001
|
| |
| 250. | Genetic evidence of an evolutionarily conserved role for Nrf2 in the protection against oxidative stress..[Mol Cell Biol,32(21),(2012),4455-4461]Mukaigasa, Katsuki Nguyen, Linh T P Li, Li Nakajima, Hitomi Yamamoto, Masayuki Kobayashi, Makoto
10.1128/MCB.00481-12
|
| |
| 251. | Nrf2-MafG heterodimers contribute globally to antioxidant and metabolic networks..[Nucleic Acids Res,40(20),(2012),10228-10239]Hirotsu, Yosuke Katsuoka, Fumiki Funayama, Ryo Nagashima, Takeshi Nishida, Yuichiro Nakayama, Keiko Engel, James Douglas Yamamoto, Masayuki
10.1093/nar/gks827
|
| |
| 252. | Targeted deletion of nrf2 impairs lung development and oxidant injury in neonatal mice..[Antioxid Redox Signal,17(8),(2012),1066-1082]Cho Hye-Youn, van Houten Bennett, Wang Xuting, Miller-Degraff Laura, Fostel Jennifer, Gladwell Wesley, Perrow Ligon, Panduri Vijayalakshmi, Kobzik Lester, Yamamoto Masayuki, Bell Douglas A, Kleeberger Steven R
|
| |
| 253. | Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis..[J Gastroenterol,47(8),(2012),924-935]Okada Kosuke, Warabi Eiji, Sugimoto Hirokazu, Horie Masaki, Tokushige Katsutoshi, Ueda Tetsuya, Harada Nobuhiko, Taguchi Keiko, Hashimoto Etsuko, Itoh Ken, Ishii Tetsuro, Utsunomiya Hirotoshi, Yamamoto Masayuki, Shoda Junichi
|
| |
| 254. | Validation of the multiple sensor mechanism of the Keap1-Nrf2 system..[Free Radic Biol Med,53(4),(2012),817-827]Takaya Kai, Suzuki Takafumi, Motohashi Hozumi, Onodera Ko, Satomi Susumu, Kensler Thomas W, Yamamoto Masayuki
|
| |
| 255. | Keap1 degradation by autophagy for the maintenance of redox homeostasis..[Proc Natl Acad Sci U S A,109(34),(2012),13561-13566]Taguchi Keiko, Fujikawa Nanako, Komatsu Masaaki, Ishii Tetsuro, Unno Michiaki, Akaike Takaaki, Motohashi Hozumi, Yamamoto Masayuki
|
| |
| 256. | NF-E2-related factor 1 (Nrf1) serves as a novel regulator of hepatic lipid metabolism through regulation of the Lipin1 and PGC-1beta genes..[Mol Cell Biol,32(14),(2012),2760-2770]Hirotsu Yosuke, Hataya Nami, Katsuoka Fumiki, Yamamoto Masayuki
|
| |
| 257. | Highly potent activation of Nrf2 by topical tricyclic bis(cyano enone): implications for protection against UV radiation during thiopurine therapy..[Cancer Prev Res (Phila),5(7),(2012),973-981]Kalra Sukirti, Knatko Elena V, Zhang Ying, Honda Tadashi, Yamamoto Masayuki, Dinkova-Kostova Albena T
|
| |
| 258. | Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming..[Cancer Cell,22(1),(2012),66-79]Mitsuishi Yoichiro, Taguchi Keiko, Kawatani Yukie, Shibata Tatsuhiro, Nukiwa Toshihiro, Aburatani Hiroyuki, Yamamoto Masayuki, Motohashi Hozumi
|
| |
| 259. | UG4 enhancer-driven GATA-2 and bone morphogenetic protein 4 complementation remedies the CAKUT phenotype in Gata2 hypomorphic mutant mice..[Mol Cell Biol,32(12),(2012),2312-2322]Ainoya Keiko, Moriguchi Takashi, Ohmori Shin'ya, Souma Tomokazu, Takai Jun, Morita Masanobu, Chandler Kelly J, Mortlock Douglas P, Shimizu Ritsuko, Engel James Douglas, Lim Kim-Chew, Yamamoto Masayuki
|
| |
| 260. | N- and C-terminal transactivation domains of GATA1 protein coordinate hematopoietic program..[J Biol Chem,287(25),(2012),21439-21449]Kaneko Hiroshi, Kobayashi Eri, Yamamoto Masayuki, Shimizu Ritsuko
|
| |
| |
